Fulgent is a technology-driven CRO company boasting a robust portfolio of clinical diagnostic and research services. Our clinical diagnostic and BioPharma business units provide a wide array of services including molecular diagnostic testing, comprehensive NGS genetic testing, RNASeq, targeted DNA / RNA panels (FFPE, Liquid Biopsy, Heme), single cell and spatial analysis (10x Genomics), proteomics (Olink) and top-tier anatomic pathology laboratory services (Immunohistochemistry (IHC), RNAscope (ISH), Akoya, Flow). These offerings are meticulously crafted to furnish physicians and patients with actionable diagnostic insights, ultimately enhancing the quality of patient care. With a dedicated focus on patient screening and enrollment testing, biomarker analysis, and companion diagnostics for clinical research, Pharma Clinical trials, and contract research, Fulgent's BioPharma Services cater to the specific needs of the pharmaceutical industry. Our overarching mission is to revolutionize the genomic diagnostic landscape, positioning ourselves as a fully integrated precision medicine company poised to drive advancements in healthcare. Fulgent has labs in US, China, and Australia.